Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellmyx is a private U.S. medical device company focused on products for harvesting, processing, and transferring autologous adipose tissue for cosmetic surgery and regenerative medicine applications. The company designs, patents, manufactures, and sells disposable and reusable devices used in liposuction, fat grafting, and related soft-tissue procedures. Its product portfolio includes intelliFat, AcquiCell, Lipo-Loop, and SuperG cannulas, which are positioned for plastic, cosmetic, reconstructive, orthopedic, and pain-management procedures. Cellmyx appears to operate commercially rather than as a therapeutic drug developer, with its value centered on procedure-enabling device technology and physician workflow solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellmyx.